Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

25 septembre 2017

09:02
WASHINGTON and BOCA RATON, Fla., Sept. 25, 2017 /PRNewswire/ -- IM HealthScience® today announced that Internal Medicine Review, a global, peer-reviewed medical journal, has published the first-ever clinical data analysis on the favorable effects of...

09:02
OSAKA, Japan and FLORHAM PARK, N.J., Sept. 25, 2017 /PRNewswire/ -- Shionogi & Co., Ltd. (hereafter "Shionogi") has announced that lusutrombopag (S-888711), an investigational, once-daily, orally administered, small molecule thrombopoietin (TPO)...

08:45
TEL AVIV, Israel, September 25, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) today announced it has filed national phase patent applications for its 'System and Method for High Throughput Screening of Cancer Cells' in the...

08:37
KFAR MALAL, Israel, September 25, 2017 /PRNewswire/ -- Medial EarlySign (www.earlysign.com), a developer of machine learning tools for data-driven medicine, today announced the results of new research with Oxford University. The study provides...

08:30
RICHLAND, Wash., Sept. 25, 2017 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and...

08:30
CLEVELAND, Sept. 25, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today the launch of a multi-center prospective clinical trial for locally advanced unresectable pancreatic cancer using MRIdian, the world's first and only FDA-cleared...

08:30
MADRID, September 25, 2017 /PRNewswire/ -- This new investigational treatment, based on RNA interference, reaches the retina when administered in eye drops. This feature is expected to positively affect patients' quality of life by eluding the use...

08:02
CAMBRIDGE, Mass., Sept. 25, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has expanded its existing clinical collaboration with Bristol-Myers Squibb evaluating IPI-549 in combination with Opdivo® to...

08:00
NESS ZIONA, Israel and CHAPEL HILL, North Carolina, Sept. 25, 2017 /PRNewswire/ -- Atox Bio today announced that it has been awarded the next option on a performance-based contract with the Biomedical Advanced Research and Development Authority...

08:00
TITUSVILLE, N.J., Sept. 25, 2017 /PRNewswire/ -- Janssen Research & Development, LLC today announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for darunavir 800mg/cobicistat 150mg/emtricitabine...

07:30
SAN DIEGO, Sept. 25, 2017 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it...

07:15
MONMOUTH JUNCTION, N.J., Sept. 25, 2017 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in critically ill and cardiac surgery patients...

07:02
RARITAN, N.J., Sept. 25, 2017 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, has announced that health and cost outcomes data from the BigpAK trial in acute kidney injury (AKI) risk assessment and management...

07:00
SAN JOSE, Calif., Sept. 25, 2017 /PRNewswire/ -- SI-BONE, Inc., an innovative medical device company which pioneered the use of the iFuse Implant System® (iFuse), a triangular-shaped minimally invasive surgical (MIS) device indicated for fusion for...

06:30
Prometic procède immédiatement à la formalisation du recrutement des sites cliniques des spécialistes aux États-Unis La demande d'un nouveau médicament de recherche sera suivie de demandes d'études cliniques au Canada, en Europe, en Australie et au...

06:30
Prometic moving immediately to formalize enrollment of specialist clinical sites across the United States U.S. IND to be followed by clinical trial applications in Canada, Europe, Australia and Japan throughout Q4 2017 Prometic plans to supplement...

06:19
NIEL, Belgium, September 25, 2017 /PRNewswire/ -- eTheRNA immunotherapies, a clinical-stage company developing mRNA-based cancer immunotherapies from its unique TriMix platform, announces it has been awarded a ?1 million industrial R&D Projects...

06:00
BEIJING, Sept. 25, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of vaccines in China, announced today preliminary top-line data from its Phase III clinical trial assessing the efficacy, immunogenicity and safety of the...

02:30
MADRID, September 25, 2017 /PRNewswire/ --   Ce nouveau traitement expérimental, basé sur l'interférence ARN, atteint la rétine lorsqu'il est administré sous forme de gouttes pour les yeux. Cette caractéristique devrait avoir un effet positif sur...

02:00
AMSTERDAM, September 25, 2017 /PRNewswire/ -- Norgine B. V. a annoncé aujourd'hui le lancement d'un nouveau document d'analyse intitulé « Scope for change: what next for European colonoscopy services? » (« Opérer des changements : quel avenir pour...

02:00
AMSTERDAM, September 25, 2017 /PRNewswire/ -- Norgine B.V. today announced it has launched a new discussion paper "Scope for change: what next for European colonoscopy services?" which identifies five key areas that pose challenges for colonoscopy...


24 septembre 2017

18:15
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their likelihood of disease recurrence and survival...

16:00
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who...

16:00
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- Long-term results of a phase III clinical trial indicate that survival rates for patients receiving chemoradiation for unresectable, locally advanced non-small cell lung cancer (NSCLC) may be more...

16:00
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy, or internal radiation therapy, for managing locally advanced cervical cancer....

16:00
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized non-small cell lung cancer (NSCLC) and afford physicians additional lead time...

16:00
SAN DIEGO, Sept. 24, 2017 /PRNewswire-USNewswire/ -- A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body's immune system to attack the...


22 septembre 2017

15:30
SAN DIEGO, Sept. 22, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today...

14:20
VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 22, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new cancer therapies, today...

08:00
DUBLIN, Sept. 22, 2017 /PRNewswire/ -- Allergan plc (NYSE:AGN) today announced top-line results from new data for the CENTAUR Phase 2b study which supports the anti-fibrotic efficacy and safety of Cenicriviroc (CVC) for the treatment of liver...

07:45
MOSCOW, September 22, 2017 /PRNewswire/ -- A group of NUST MISIS scientists jointly with their colleagues from the Saha Institute of Nuclear Physics (Kolkata, India) have managed to synthesize stable gold nanoparticles in the shape of a star...

07:00
NORTH CHICAGO, Ill. and NEW YORK, Sept. 22, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a clinical trial collaboration to evaluate the combination of AbbVie's investigational antibody drug...

03:20
Denmark's Aarhus University to Use Signateratm ctDNA Technology in Longitudinal Study SAN CARLOS, California and AARHUS, Denmark, Sept. 22, 2017 /PRNewswire/ -- Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered...

03:20
L'Université d'Aarhus au Danemark utilisera la technologie d'ADNtc Signateratm dans le cadre d'une étude longitudinale SAN CARLOS, Californie et AARHUS, Danemark, le 22 septembre 2017 /PRNewswire/ -- Natera, Inc., (NASDAQ : NTRA), leader mondial...


21 septembre 2017

12:14
LOS ANGELES, Sept. 21, 2017 /PRNewswire/ -- DxTerity announced today that it is collaborating with the City of Hope Medical Center on the clinical development of a blood test that could possibly predict whether cancer patients about to undergo...

08:47
NEW YORK and TORONTO, Sept. 21, 2017 /PRNewswire-USNewswire/ -- As Global Biotech Week begins in more than 20 countries, JDRF, the leading organization funding type 1 diabetes (T1D) research, is pleased to announce that it will contribute funding...

08:00
SAN DIEGO, Sept. 21, 2017 /PRNewswire/ -- Patara Pharma, a clinical-stage biopharmaceutical company developing therapeutics that significantly improve the lives of patients with chronic inflammatory lung diseases and immune disorders, today announced...

08:00
SAN FRANCISCO, Sept. 21, 2017 /PRNewswire/ -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today...

07:30
LEBANON, N.J., Sept. 21, 2017 /PRNewswire/ -- Provention Bio, Inc., a clinical stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics aimed at intercepting and preventing immune-mediated diseases,...

03:13
DARMSTADT, Germany and NEW YORK, USA, September 21, 2017 /PRNewswire/ -- Not intended for UK-based media       First approved immunotherapy for rare and aggressive skin cancer in the European Union, with initial launches planned in Germany...

02:54
LUND, Sweden, Sept. 21, 2017 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that results from a clinical phase I study...


20 septembre 2017

18:20
CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire-USNewswire/ -- The Angiogenesis Foundation announced today its President and Medical Director, Dr. William Li, will present new groundbreaking scientific and public health data connecting diet with health...

14:01
CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire/ -- In a landmark study published in the journal Science today, researchers produced genetically engineered antibodies with the highest activity and breadth of coverage yet seen against human...

13:00
REYKJAVIK, Iceland, September 20, 2017 /PRNewswire/ -- The generation of new mutations is a key driver of evolution but also of susceptibility to rare diseases Fathers pass on four times as many new mutations as mothers do, but the...

11:03
SAN CARLOS, Calif., Sept. 20, 2017 /PRNewswire/ -- Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Denmark's Aarhus University to leverage the company's Signateratm (RUO)...

10:36
AMSTERDAM, September 20, 2017 /PRNewswire/ -- Norgine B.V. a annoncé aujourd'hui le lancement de LYMPHOSEEK® (technetium Tc 99m tilmanocept) en Italie. LYMPHOSEEK® est un produit radiopharmaceutique utilisé à des fins de diagnostic par les...

10:31
NEW YORK, Sept. 20, 2017 /PRNewswire/ -- AbleTo, Inc., the leading provider of technology-enabled behavioral health solutions proven to improve patient outcomes and lower healthcare costs, announced that Telemedicine and e-Health has published the...

09:02
CAESAREA, Israel and EINDHOVEN, Netherlands, Sept. 20, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a smart diabetes solution, and HighTechXL, a corporate-backed accelerator based in Eindhoven, The Netherlands, announce their strategic...

08:30
MADRID, September 20, 2017 /PRNewswire/ -- With the motivation of finding a solution to the unmet needs of patients with different types of cancer, PharmaMar (MCE:PHM) announces the start of a Phase I clinical study with PM14, a new antitumor...

08:18
SAN DIEGO, Sept. 20, 2017 /PRNewswire/ -- Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, and its research collaborators will present eight posters...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17